Effect of Carbohydrate Consumption on Fatigue and Muscle Damage in Jiu-Jitsu Athletes

January 15, 2019 updated by: Cláudia Dornelles Schneider, Federal University of Health Science of Porto Alegre

Effect of Carbohydrate Consumption on Fatigue and Muscle Damage in Jiu-Jitsu Athletes: A Randomized Clinical Trial

The study is a randomized, double-blinded, placebo-controlled trial that will include the participation of 14 Jiu-Jitsu athletes between 18 and 33 years. The aim of the study is to evaluate the effects of carbohydrate consumption on fatigue and exercise-induced muscle damage in Jiu-Jitsu athletes.

Study Overview

Detailed Description

Brazilian Jiu-Jitsu (BJJ) is a sport characterized by intermittent high-intensity efforts separated by periods of low intensity. Muscular strength is considered one of the most important physical components to be developed, especially in the upper limbs through dynamic and static actions. The activities of high intensity (relation effort-pause) carried out by the upper and lower limbs during BJJ can induce muscle fatigue. In order to minimize the glycogen depletion and to guarantee the availability of energy substrate to the athlete during the physical exercise, the carbohydrate intake before moderate intensity exercises should be between 5-7 g / kg of weight / day. The intervention group will receive a 30g maltodextrin beverage and the placebo group a non-carbohydrate drink. There will be 3 combat simulations of 8 min each, with intervals of 10 min between fights. Athletes will be instructed to remain with their usual intake during the study. The outcomes will be: manual grip strength (dynamometer), upper limb strength (KGST), lower limb strength (vertical jump), subjective exertion perception (Borg scale), pain perception (Nilsson scale), blood markers of muscle damage (CK and LDH), lactate, and glycemia.

Study Type

Interventional

Enrollment (Actual)

14

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande Do Sul
      • Pôrto Alegre, Rio Grande Do Sul, Brazil, 90050170
        • Gabriella B. Möller

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 33 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Compete in the categories of weight between 70kg and 88,3kg (weight classification from light to medium heavy, belonging to the bands purple to brown).
  • Age between 18 and 33 years.
  • Be training at least three times a week, minimum of 1,5 hours per day, for at least 3 consecutive months.
  • Have not used anabolic steroids in the last 6 months during the study period.
  • Do not use any type of dietary supplement in the last 3 months.
  • Self-declared healthy individuals.

Exclusion Criteria:

  • Recent muscle injury (within the last 3 months) that compromises and / or impedes the performance of the exercise requested in the study.
  • Be in a time of rapid weight loss (pre-competition).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Carbohydrate
30g of carbohydrate (maltodextrin) diluted in 300ml of water. Athletes will drink 100ml before and 100ml in the first and second interval between exercise.
maltodextrin flavored
Placebo Comparator: Placebo
300 ml of a non-caloric drink. Athletes will drink 100ml before and 100ml in the first and second interval between exercise.
non-caloric drink

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in upper limbs strength
Time Frame: Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise
Kimono Grip Strength Test
Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in lower limbs power
Time Frame: Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise
Horizontal Countermovement Jump
Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise
change in hand grip strength
Time Frame: Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise
Grip Strength Test
Pre-exercise; at 2 intervals during exercise; 24hour and 48hour after exercise
change in creatine kinase
Time Frame: Pre-exercise; immediatly post-exercise; 24hour and 48hour after exercise
3 ml of blood samples
Pre-exercise; immediatly post-exercise; 24hour and 48hour after exercise
change in glucose
Time Frame: Pre-exercise; at 2 intervals during exercise; immediatly post-exercise
fingertip blood measured by Accutrend® Active glucose-specific reagent tape
Pre-exercise; at 2 intervals during exercise; immediatly post-exercise
change in lactate
Time Frame: At 2 intervals during exercise; immediatly post-exercise
fingertip blood measured by Accutrend Plus.
At 2 intervals during exercise; immediatly post-exercise
change in lactate dehydrogenase
Time Frame: Pre-exercise; immediatly post-exercise; 24hour and 48hour after exercise
3 ml of blood samples
Pre-exercise; immediatly post-exercise; 24hour and 48hour after exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Claudia D Schneider, PhD, Federal University of Health Science of Porto Alegre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 26, 2017

Primary Completion (Actual)

December 31, 2017

Study Completion (Actual)

December 31, 2017

Study Registration Dates

First Submitted

June 26, 2017

First Submitted That Met QC Criteria

June 28, 2017

First Posted (Actual)

June 29, 2017

Study Record Updates

Last Update Posted (Actual)

January 16, 2019

Last Update Submitted That Met QC Criteria

January 15, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1.873.861

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Carbohydrate (maltodextrin)

3
Subscribe